Investing.com - Maravai Lifesciences reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Maravai Lifesciences announced earnings per share of $0.37 on revenue of $191.3M (NYSE:MMM). Analysts polled by Investing.com anticipated EPS of $0.34 on revenue of $195.4M.
Maravai Lifesciences shares are up 17.79% from the beginning of the year and are trading at $14.34 , down-from-52-week-high.
Maravai Lifesciences shares lost 6.64% in after-hours trade the report.
Maravai Lifesciences follows other major Healthcare sector earnings this month
Maravai Lifesciences's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar